OliX Pharmaceuticals, Inc (KOSDAQ: 226950)

OliX Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 19, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	284,258	233,568	278,859	561,830	681,166	276,877
Market Cap Growth	28.75%	-16.24%	-50.37%	-17.52%	146.02%	-37.76%
Enterprise Value	321,428	247,386	238,494	524,125	657,538	236,593
Last Close Price	16490.00	14580.00	20350.00	41000.00	50300.00	21200.00
PS Ratio	16.85	13.69	29.92	152.91	275.30	244.95
PB Ratio	17.55	4.64	4.21	28.95	15.02	6.62
P/TBV Ratio	19.62	4.92	4.48	34.29	15.93	6.86
EV/Sales Ratio	19.92	14.50	25.59	142.64	265.75	209.31
Debt / Equity Ratio	2.88	0.78	0.66	1.92	0.32	0.01
Asset Turnover	0.17	0.14	0.08	0.04	0.04	0.02
Inventory Turnover	0.34	0.28	0.40	0.51	0.17	0.11
Quick Ratio	0.35	4.71	1.59	1.24	15.21	12.98
Current Ratio	0.42	4.90	1.64	1.29	15.38	13.59
Return on Equity (ROE)	-87.14%	-32.78%	-65.68%	-90.11%	-44.48%	-29.67%
Return on Assets (ROA)	-14.18%	-9.65%	-12.75%	-18.33%	-16.40%	-18.74%
Return on Capital (ROIC)	-17.44%	-11.37%	-16.76%	-25.98%	-19.92%	-19.49%
Earnings Yield	-9.30%	-8.18%	-6.99%	-5.29%	-2.85%	-5.18%
FCF Yield	-12.26%	-12.84%	-11.80%	-3.62%	-0.67%	-4.24%
Buyback Yield / Dilution	-19.09%	-5.30%	-0.13%	-4.06%	-1.00%	-12.26%
Total Shareholder Return	-19.09%	-5.30%	-0.13%	-4.06%	-1.00%	-12.26%

Source: S&P Capital IQ. Standard template. Financial Sources.